Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;129(3):339.e19-26.
doi: 10.1016/j.amjmed.2015.10.014. Epub 2015 Nov 18.

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies

Elizabeth J Bell  1 , Pamela L Lutsey  2 , Saonli Basu  3 , Mary Cushman  4 , Susan R Heckbert  5 , Donald M Lloyd-Jones  6 , Aaron R Folsom  2
Affiliations

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies

Elizabeth J Bell et al. Am J Med. 2016 Mar.

Abstract

Background: Greater public awareness of venous thromboembolism may be an important next step for optimizing venous thromboembolism prevention and treatment. "Lifetime risk" is an easily interpretable way of presenting risk information. Therefore, we sought to calculate the lifetime risk of venous thromboembolism (deep vein thrombosis or pulmonary embolism) using data from 2 large, prospective cohort studies: the Cardiovascular Health Study (CHS) and the Atherosclerosis Risk in Communities (ARIC) study.

Methods: We followed participants aged 45-64 years in ARIC (n = 14,185) and ≥65 in CHS (n = 5414) at baseline visits (1987-1989 in ARIC, 1989-1990 and 1992-1993 in CHS) for incident venous thromboembolism (n = 728 in ARIC through 2011 and n = 172 in CHS through 2001). We estimated lifetime risks and 95% confidence intervals of incident venous thromboembolism using a modified Kaplan-Meier method, accounting for the competing risk of death from other causes.

Results: At age 45 years, the remaining lifetime risk of venous thromboembolism in ARIC was 8.1% (95% confidence interval, 7.1-8.7). High-risk groups were African Americans (11.5% lifetime risk), those with obesity (10.9%), heterozygous for the factor V Leiden (17.1%), or with sickle cell trait or disease (18.2%). Lifetime risk estimates differed by cohort; these differences were explained by differences in time period of venous thromboembolism ascertainment.

Conclusions: At least 1 in 12 middle-aged adults will develop venous thromboembolism in their remaining lifetime. This estimate of lifetime risk may be useful to promote awareness of venous thromboembolism and guide decisions at both clinical and policy levels.

Keywords: Embolism; Epidemiology; Risk factors; Thrombosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cohort- and age- specific venous thromboembolism incidence rates by time period of venous thromboembolism ascertainment.
See this image and copyright information in PMC

References

    1. Office of the Surgeon General (US) The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD: 2008. - PubMed
    1. American Public Health Association Deep-Vein Thrombosis: Advancing Awareness to Protect Patient Lives. Public Health Leadership Conference on Deep-Vein Thrombosis. White Paper.
    1. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis : A major contributor to global disease burden #2729 ISTH Steering Committee for World Thrombosis Day The members of the ISTH Steering Committee for World Thrombosis Day : Thromb Res. 2014;134(5):931–938. doi:10.1016/j.thromres.2014.08.014. - PubMed
    1. Sasieni PD, Adams J. Standardized lifetime risk. Am J Epidemiol. 1999;149(9):869–875. - PubMed
    1. Fortin JM, Hirota LK, Bond BE, O'Connor AM, Col NF. Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak. 2001;1:2. - PMC - PubMed

Publication types

Grants and funding

LinkOut - more resources